Bomman Shivanand, Sanders David, Coy David, La Selva Danielle, Pham Quincy, Zehr Troy, Law Joanna, Larsen Michael, Irani Shayan, Kozarek Richard A, Ross Andrew, Krishnamoorthi Rajesh
Center for Digestive Health, Virginia Mason Franciscan Health, 1100, 9th Avenue, Mail stop: C3-GAS, Seattle, WA, 98101, USA.
Surg Endosc. 2023 Feb;37(2):902-911. doi: 10.1007/s00464-022-09561-8. Epub 2022 Aug 29.
Necrotizing pancreatitis can be complicated by Necrotic Fluid Collections (NFC). Guidelines recommend waiting for 4 weeks from the onset of acute pancreatitis (AP) before considering endoscopic drainage. We aimed to compare outcomes and safety in patients undergoing early versus late drainage of NFC.
We performed a retrospective review of all patients who underwent Dual Modality Drainage (DMD) [combined endoscopic and percutaneous drainage] for NFC from January 2007 to December 2020. Patients were stratified into the "early" group (DMD < 28 days from AP onset) and were matched to "late" (DMD ≥ 28 days) drainage group using propensity- core-matching. Primary outcomes of interest were technical success and adverse events. Secondary outcomes included clinical success, late complication rates, and mortality.
We identified 278 patients who underwent DMD for NFC. Thirty-nine belonged to the early group and were matched to 174 patients from the late group. Technical success was similar in both early and late groups (97.4% vs 99.4%: P = 0.244) as were the procedural and early post-procedural (< 14 days) adverse events rates (23.1% vs 27.6%: P = 0.565). Clinical success (92.3% vs 93.1%; P = 0.861) and late complication rates (23.1% vs 31.6%; P = 0.294) were similar. There were 2 deaths (5.7%) in the early vs. 9 (5.2%) in the late group, P = 0.991.
When performed in a tertiary care center with expertise in therapeutic endoscopic ultrasound, early drainage of NFC appears to be feasible and safe. Further studies are needed to validate our results.
坏死性胰腺炎可并发坏死性液体积聚(NFC)。指南建议在急性胰腺炎(AP)发作后等待4周再考虑内镜引流。我们旨在比较早期与晚期引流NFC患者的治疗效果和安全性。
我们对2007年1月至2020年12月期间所有接受双模式引流(DMD)[内镜和经皮联合引流]治疗NFC的患者进行了回顾性研究。将患者分为“早期”组(DMD在AP发作后<28天),并使用倾向核心匹配法与“晚期”(DMD≥28天)引流组进行匹配。主要关注的结果是技术成功率和不良事件。次要结果包括临床成功率、晚期并发症发生率和死亡率。
我们确定了278例接受DMD治疗NFC的患者。39例属于早期组,并与174例晚期组患者进行了匹配。早期和晚期组的技术成功率相似(97.4%对99.4%:P = 0.244),操作及术后早期(<14天)不良事件发生率也相似(23.1%对27.6%:P = 0.565)。临床成功率(92.3%对93.1%;P = 0.861)和晚期并发症发生率(23.1%对31.6%;P = 0.294)相似。早期组有2例死亡(5.7%),晚期组有9例死亡(5.2%),P = 0.991。
在具备治疗性内镜超声专业知识的三级医疗中心进行NFC早期引流似乎是可行且安全的。需要进一步研究来验证我们的结果。